Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives

por Sener, Ugur, Ruff, Michael W., Campian, Jian L.
Publicado 2022

Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the National Cance...

por Kerezoudis, Panagiotis, Yolcu, Yagiz Ugur, Laack, Nadia N, Ruff, Michael W, Khatua, Soumen, Daniels, David J, Burns, Terry C, Kizilbash, Sani H
Publicado 2022

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

por Cox, Michelle J., Roman, Claudia Manriquez, Tapper, Erin E., Siegler, Elizabeth L., Chappell, Dale, Durrant, Cameron, Ahmed, Omar, Sinha, Sutapa, Mwangi, Raphael, Scott, Nancy S., Hefazi, Mehrdad, Schick, Kendall J., Horvei, Paulina, Ruff, Michael W., Can, Ismail, Adada, Mohamad, Bezerra, Evandro, Fonkoua, Lionel Aurelien Kankeu, Parikh, Sameer A., Kay, Neil E., Sakemura, Reona, Kenderian, Saad S.
Publicado 2022

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients

por Webb, M J, Neth, Bryan J, Webb, Lauren M, Van Gompel, Jamie J, Link, Michael J, Neff, Brian A, Carlson, Matthew L, Driscoll, Colin L, Dornhoffer, Jim, Ruff, Michael W, Anderson, Kelsey A, Kizilbash, Sani H, Campian, Jian L, Uhm, Joon H, Lane, Jack I, Benson, John C, Blezek, Daniel J, Mehta, Parv M, Bathla, Girish, Sener, Ugur T
Publicado 2023